Not publicly disclosed IPOs
6 companies in Not publicly disclosed tracking toward an IPO in 2026.
Aevex Corp.
Aevex Corp. is a defense and aerospace company specializing in intelligence, surveillance, and reconnaissance (ISR) solutions for government and military clients. The company provides advanced technology services and platforms for national security applications, making it attractive to investors interested in the growing defense technology sector.
FutureCorp Space Acquisition I
FutureCorp Space Acquisition I is a special purpose acquisition company (SPAC) likely focused on the commercial space industry and aerospace sector. The SPAC aims to identify and merge with a private space or aerospace technology company. Investors are interested in this vehicle given the growing commercial space market.
InterPrivate Investment Partners V
InterPrivate Investment Partners V is a special purpose acquisition company (SPAC) formed to identify and merge with a private company to take it public. The SPAC targets businesses in the consumer, media, and technology sectors. Investors monitor this vehicle for its potential acquisition target announcement.
Long Table Growth Corp.
Long Table Growth Corp. is a special purpose acquisition company (SPAC) designed to merge with a private company and facilitate its public listing. The SPAC focuses on identifying high-growth businesses across various sectors. Investors track this vehicle for announcements regarding its merger target and IPO plans.
Maywood Acquisition Corp. 2
Maywood Acquisition Corp. 2 is a special purpose acquisition company (SPAC) formed to identify and merge with a private company to take it public. SPACs have become a popular alternative to traditional IPOs, offering investors a way to invest in pre-identified acquisition targets.
Parabilis Medicines
Parabilis Medicines is a biotechnology company focused on developing novel therapeutics for serious diseases. The company works on advancing drug candidates through clinical development with the goal of addressing unmet medical needs. Investors monitor biotech IPOs like Parabilis for breakthrough therapies and commercial potential.
Track Not publicly disclosed IPOs
Get daily alerts when companies in Not publicly disclosed file S-1s or announce IPO dates.
Get IPO Alerts